Cite
APA Citation
Petrylak, D. P., Rosenberg, J., Duran, I., Loriot, Y., Sonpavde, G., Wu, C., Gartner, E., Melhem-Bertrandt, A., & Powles, T. (n.d.). 922TiPEV-301: An open-label, randomized phase III study to evaluate enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (la/mUC). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095320925.0x000039